Click here to read about some of the people we've helped.  We're here to help you, too. Get four essential health reports when you join our e-news community.

FREE REPORT. Your key pointers to a life-transforming diet

Find out the best diet for you in one of four free reports we'll give you when you join the WDDTY community. We'll also send you up-to-the-moment health news and advice twice a week, packed full of insights that may well transform your own health.

First Name:Email:


Doctors training notes

A malignant mystery

I recently underwent a radical prostate tomy in Athens. It was successful, and I praise the Greek surgeons. But was it necessary? When in the US I had decided to have a check up, since a recent PSA count had been rather high. I had no symptoms except an occasional urge to urinate more frequently. The biopsy report, sent to me in Athens, noted five slides showing benign prostate hyperplasia and one showing "a single focus of adenocarcinoma".

The Athens surgeon (Edinburgh trained) recommended immediate surgery. "Watchful waiting" was discouraged. So was a second biopsy: "Even if we found a negative, we would have to honour the findings that show adenocarcinoma." It was done. But when the gland was examined in the lab, there was no sign of malignancy. Was it possible that the biopsy removed the single speck of carcinoma? "Possible, but not likely," I was told.

I had the surgeon write to the US clinic. They sent the slides, with a letter from the pathologist saying the rest of his department had reviewed them and all had "independently agreed" his finding.

I began to feel borderline suspicion. Members of the same department that's not what I call independent. Someone told me about the American Medical Association, and the fear of claims being brought. The chief pathologist at the Athens hospital reviewed the slides, and found no malignancy whatever. On his own initiative, he sent them to the professor of pathology at the University. The finding: the same.

"Claims" was not my intention. But I wanted to understand. The Athens pathologist suggested an eminent US specialist, who agreed to review the slides. I sent them with nothing to identify their source, apart from the accession numbers (sent at his request). When he returned them, he enclosed a letter not to me, but to the US clinic, and the very pathologist involved!

The letter backs up the clinic's finding and adds: "If follow up becomes available I would appreciate your letting me know." In other words: "If this bloke gives you any trouble, I'm on your side!"

Am I being overly suspicious? I don't believe so. After hearing a few stories about the AMA, it all smacks of collusion. A L, Athens.



WDDTY Blog Speak

Psa: - A test for anyone's belief - Regular readers will know that the PSA (prostate specific antigen) test is one of the most useless in the whole armoury of medical procedures. It's,...

Prostate cancer: wait and see - The idea of "watchful waiting" as a method of dealing with prostate cancer has gained more ground following a study in Sweden, which has the world's f...

The psa test - More than 10,000 cases of cancer of the prostate, the walnut-sized gland that sits just below the bladder, are diagnosed every year in the UK. It is t...

The psa test - Just what is it good for? - Screening for prostate cancer is surrounded by controversy - and with good reason. Although deaths due to prostate cancer have gone down since 1985, w...

Enlarged prostate - Although the conventional approach to an enlarged prostate (also known as benign prostatic hyperplasia or BPH) is drugs or sometimes even surgery, the...

Breast implants: safety row - Ignoring mounting evidence of the dangers of silicon gel breast implants, the American Medical Association has endorsed a report recommending their us...

The problem with the psa test - The prostate is a walnut-sized organ that sits invisibly between the rectum and scrotum, close up against the bladder. It surrounds the urethra,

Drugs for prostate cancer - What to do instead - While factors such as race and family history make certain groups more vulnerable to prostate cancer, age is the biggest risk indicator across the boa...